Population Pharmacokinetics of Imatinib in CML Patients in Iran
Sponsor: Kerman University of Medical Sciences
Terminated
This trial was terminated. No reason was provided.
Other Chronic Myelogenous Leukemia trials with similar outcome
A observational or N/A phase clinical study on Chronic Myelogenous Leukemia, this trial is terminated or withdrawn. The trial is conducted by Kerman University of Medical Sciences and has accumulated 7 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Sep 2024 — Sep 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Terminated NA
First recorded
Oct 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Kerman University of Medical Sciences
For direct contact, visit the study record on ClinicalTrials.gov .